日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice

流感B型嵌合HA mRNA-LNP疫苗具有交叉反应性,并且在小鼠中具有保护作用。

González-Domínguez, Irene; Boza, Marta; Abdeljawad, Adam; Shea, William; Puente-Massaguer, Eduard; Mishra, Mitali; Lemus, Nicholas; Lai, Tsoi Ying; Muramatsu, Hiromi; Lam, Kieu; Heyes, James; Martínez-Guevara, Jose Luis; Krammer, Florian; Palese, Peter; Pardi, Norbert; Sun, Weina

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination

接种KP.2单价mRNA疫苗后,针对SARS-CoV-2变异株LP.8.1、LF.7.1、NB.1.8.1、XFG和BA.3.2的抗体反应

Abbad, Anass; Lerman, Brian; Ehrenhaus, Jordan; Monahan, Brian; Singh, Gagandeep; Wilson, Adria; Slamanig, Stefan; Aracena, Ashley; Lyttle, Neko; Nardulli, Jessica R; Farrugia, Keith; Khalil, Zain; Gonzalez-Reiche, Ana Silvia; Sordillo, Mia Emilia; Sun, Weina; van Bakel, Harm; Simon, Viviana; Krammer, Florian

SARS-CoV-2 Nsp15 facilitates immune evasion and viral replication by limiting multiple host innate immune pathways, including cGAS-STING.

SARS-CoV-2 Nsp15 通过限制多种宿主先天免疫途径(包括 cGAS-STING)来促进免疫逃避和病毒复制。

Chiu Hsin-Ping, Yeo Yao Yu, Lai Tsoi Ying, Hung Chuan-Tien, Kowdle Shreyas, Haas Griffin D, Jiang Sizun, Sun Weina, Lee Benhur

Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1

更正:在感染 HIV-1 的人群中,接种 COVID-19 mRNA 疫苗后 Fc 介导的抗体反应降低

Klingler, Jéromine; Rao, Priyanka Gadam; Bandres, Juan C; Pena, Ismael; Roldan, Katherine Bolanos; Singh, Gagandeep; Monahan, Brian; Gleason, Charles; Chen, Yuexing; Slamanig, Stefan; Sun, Weina; Upadhyay, Chitra; Hioe, Catarina E

Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines

开发RT-qPCR和下一代测序方法来评估基于NDV的SARS-CoV-2变异疫苗的病毒脱落情况

Boza, Marta; Abdeljawad, Adam; Slamanig, Stefan; Lemus, Nicholas; Lai, Tsoi Ying; Shea, William; Sun, Weina; Palese, Peter; González-Domínguez, Irene

AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice

AddaVax、AddaS03 和明矾可有效增强灭活 NDV-HXP-S 疫苗在小鼠体内诱导的针对 SARS-CoV-2 的交叉反应性和交叉中和性抗体反应。

Martínez-Guevara, José Luis; Lai, Tsoi Ying; Mishra, Mitali; Slamanig, Stefan; González-Domínguez, Irene; Abdeljawad, Adam; Hoang, Minh Thu; Singh, Gagandeep; Kowdle, Shreyas; Lee, Benhur; Krammer, Florian; Palese, Peter; Sun, Weina

Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine

一项评估AVX/COVID-19疫苗单剂加强剂量安全性、免疫原性和非劣效性的II/III期研究

López-Macías, Constantino; Torres, Martha; Armenta-Copca, Brenda; Wacher, Niels H; Galindo-Fraga, Arturo; Castro-Castrezana, Laura; Colli-Domínguez, Andrea Alicia; Cervantes-Trujano, Edgar; Rucker-Joerg, Isabel Erika; Lozano-Patiño, Fernando; Rivera-Alcocer, Juan José; Simón-Campos, Abraham; Sánchez-Campos, Efrén Alberto; Aguirre-Rivero, Rafael; Muñiz-Carvajal, Alejandro José; Del Carpio-Orantes, Luis; Márquez-Díaz, Francisco; Rivera-Hernández, Tania; Torres-Flores, Alejandro; Ramírez-Martínez, Luis; la Rosa, Georgina Paz-De; Rojas-Martínez, Oscar; Suárez-Martínez, Alejandro; Peralta-Sánchez, Gustavo; Carranza, Claudia; Juárez, Esmeralda; Zamudio-Meza, Horacio; Carreto-Binaghi, Laura E; Viettri, Mercedes; Romero-Rodríguez, Damaris; Palencia, Andrea; Sarfati-Mizrahi, David; Sun, Weina; Chagoya-Cortés, Héctor Elías; Castro-Peralta, Felipa; Palese, Peter; Krammer, Florian; García-Sastre, Adolfo; Lozano-Dubernard, Bernardo

Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens

流感病毒1组嵌合血凝素作为广谱疫苗免疫原的结构表征

Nguyen, Yen Thi Kim; Zhu, Xueyong; Han, Julianna; Rodriguez, Alesandra J; Sun, Weina; Yu, Wenli; Palese, Peter; Krammer, Florian; Ward, Andrew B; Wilson, Ian A

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters.

同源和异源 NDV 和 MVA SARS-CoV-2 疫苗在小鼠和仓鼠中的免疫原性和有效性。

Pérez Patricia, Jiang Kaijun, González-Domínguez Irene, Rodríguez-Martín Daniel, Abdeljawad Adam, Cupic Anastasija, Slamanig Stefan, Flores Sara, Noriega María A, Sánchez-Cordón Pedro J, Lemus Nicholas, Lai Tsoi Ying, Sun Weina, Esteban Mariano, García-Sastre Adolfo, García-Arriaza Juan

Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 'Patria' vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version.

应对 SARS-CoV-2 的演变:AVX/COVID-12“Patria”疫苗基于 HexaPro-S 祖先武汉刺突蛋白或其更新的 BA.2.75.2 版本,可中和令人担忧的新出现的变异株

Carballo-Uicab Gregorio, Mellado-Sánchez Gabriela, González-González Edith, Salinas-Trujano Juana, Mendoza-Salazar Ivette, López-Olvera Karina, Gómez-Castellano Keyla M, Salazar Ma Isabel, Torres-Flores Jesús M, Chagoya-Cortés Héctor Elías, Paz-De la Rosa Georgina, Mena Ignacio, Rojas-Martínez Oscar, Lara-Puente Jesús Horacio, Peralta-Sánchez Gustavo Javier, Sarfati-Mizrahi David, Torres-Flores Alejandro, Sun Weina, Krammer Florian, García-Sastre Adolfo, Palese Peter, López-Macías Constantino, Lozano-Dubernard Bernardo, Pérez-Tapia Sonia M, Almagro Juan C